Related Experiment Videos
Anemia and the elderly: clinical considerations.
1Department of Medicine/Division of Hematology, Medical Oncology, Mount Sinai School of Medicine, One Gustave L. Levy Place, NY 10029, USA. janice.gabrilove@mssm.edu
Best Practice & Research. Clinical Haematology
|March 29, 2005
Summary
Anemia in elderly patients significantly increases morbidity and mortality risks. Further research is needed to determine the impact of erythropoietic therapy on age-related health issues.
Area of Science:
- Geriatrics
- Hematology
Background:
- Anemia is prevalent in elderly patients, correlating with increased morbidity, mortality, and poor health outcomes.
- It acts as an independent risk factor for cardiovascular disease, early death, fatigue, and diminished quality of life in older adults.
Purpose of the Study:
- To explore the implications of anemia in the elderly population.
- To investigate the potential role of erythropoietic agents in managing anemia-related complications in older individuals.
Main Methods:
- Review of existing literature on anemia in the elderly.
- Analysis of the pathophysiology of anemia in chronic disease settings.
Main Results:
- Anemia in the elderly is associated with adverse outcomes, including cardiovascular risks and functional decline.
- Understanding anemia's pathophysiology supports the potential use of erythropoietic agents.
Conclusions:
- Anemia is a critical health concern in the elderly, linked to increased mortality and reduced quality of life.
- The impact of erythropoietic therapy on specific geriatric conditions requires further investigation.